{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-09-16T12:22:35.688758+00:00",
  "news": [
    {
      "title": "Amgen: Buy The Dip Opportunity (NASDAQ:AMGN) - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMidEFVX3lxTFBUU2hsUzBiWHNoSE5vZzdOTXlPelZYUE04elA2VFZoTUFEVTlXZ3ZhbTFrVTVtcWc5UmJ5ZEtTbnNTRllmS3lOd1RyUlVzdElGSUVTQVVEcGQxeEFMd19TX1M5LXZxc1V1dDd2SUdUQlROV2Ns?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMidEFVX3lxTFBUU2hsUzBiWHNoSE5vZzdOTXlPelZYUE04elA2VFZoTUFEVTlXZ3ZhbTFrVTVtcWc5UmJ5ZEtTbnNTRllmS3lOd1RyUlVzdElGSUVTQVVEcGQxeEFMd19TX1M5LXZxc1V1dDd2SUdUQlROV2Ns?oc=5\" target=\"_blank\">Amgen: Buy The Dip Opportunity (NASDAQ:AMGN)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-09-14T12:30:38+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOLWVZSUxxN1pZc3F2Q3FjMkJqMWg3MS13NVBrR0xlakZBVGVRcG8zSTJ6MUFsSm5nUFQxTHhpQngxWFRrSXc5ZFYxa1BwVm1oMEFqWkM5bGxURlYtVFI0eDF1ZGUxMGEtczRDWlU1X1FVZDhvOTZNdkgyZ1hYU0ZyRg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigAFBVV95cUxOLWVZSUxxN1pZc3F2Q3FjMkJqMWg3MS13NVBrR0xlakZBVGVRcG8zSTJ6MUFsSm5nUFQxTHhpQngxWFRrSXc5ZFYxa1BwVm1oMEFqWkM5bGxURlYtVFI0eDF1ZGUxMGEtczRDWlU1X1FVZDhvOTZNdkgyZ1hYU0ZyRg?oc=5\" target=\"_blank\">Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-09-15T13:00:02+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Global biotech leaders Amgen and Gilead announcing expansions in California, the #1 state for life sciences - Governor of California (.gov)",
      "link": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxQNkFQNVUxYWlJQU1YZlpBSXFrUEotWnBHU1hEQ0lmcU0wR25nX3hETGkxV2M2UVN5NW5ZNHdjYS03NVAyUTBWVjJIZkRyUmR3cXBfUVFjUHVDWDFhYlZSTEhqTlFyenIyNXphZXcyVzNLMml4dlhxeG1qa1dWck1uY1J0SmdaeW9NQ3JmOHNZcnpBR1V2cVAyaXZIXzcxYkFWR3FyTi01NWtFaGE4WGZtbFRlOEQ2ajFJdGpRQ2FDbnBXd3RwbVZob2lJQzZVQWVXOU9VWkxscw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQNkFQNVUxYWlJQU1YZlpBSXFrUEotWnBHU1hEQ0lmcU0wR25nX3hETGkxV2M2UVN5NW5ZNHdjYS03NVAyUTBWVjJIZkRyUmR3cXBfUVFjUHVDWDFhYlZSTEhqTlFyenIyNXphZXcyVzNLMml4dlhxeG1qa1dWck1uY1J0SmdaeW9NQ3JmOHNZcnpBR1V2cVAyaXZIXzcxYkFWR3FyTi01NWtFaGE4WGZtbFRlOEQ2ajFJdGpRQ2FDbnBXd3RwbVZob2lJQzZVQWVXOU9VWkxscw?oc=5\" target=\"_blank\">Global biotech leaders Amgen and Gilead announcing expansions in California, the #1 state for life sciences</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Governor of California (.gov)</font>",
      "published": "2025-09-15T17:59:38+00:00",
      "source": "Governor of California (.gov)"
    },
    {
      "title": "Amgen and Kyowa Kirin announce rocatinlimab results for atopic dermatitis - PMLiVE",
      "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNMGFjUGtQLUFHOHExbnN4bl85cmNuQTMtMkpBN2lwUWRjTjFpZHdGc25oUzRWUnhRN0d0eEhiMzRLN0ltdXFveWdOZlhUbnNhOHZ3YW8xb0x1M2ppVkJaUDduNGZaUWIyOGpYRjg2RFRyQlZuTWdxZDNCRjZyV0N4ODNQa00xemxlcHRfOGwxVmw0a283RVlHREJnSDlweWxQSGJZbHlaYWM?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNMGFjUGtQLUFHOHExbnN4bl85cmNuQTMtMkpBN2lwUWRjTjFpZHdGc25oUzRWUnhRN0d0eEhiMzRLN0ltdXFveWdOZlhUbnNhOHZ3YW8xb0x1M2ppVkJaUDduNGZaUWIyOGpYRjg2RFRyQlZuTWdxZDNCRjZyV0N4ODNQa00xemxlcHRfOGwxVmw0a283RVlHREJnSDlweWxQSGJZbHlaYWM?oc=5\" target=\"_blank\">Amgen and Kyowa Kirin announce rocatinlimab results for atopic dermatitis</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PMLiVE</font>",
      "published": "2025-09-16T11:59:18+00:00",
      "source": "PMLiVE"
    },
    {
      "title": "Biotech company Amgen set to build $600-million research center in Thousand Oaks - Los Angeles Times",
      "link": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOT0lTMzdJb2diVXhDLTBMRE9xdmVjOHJUS0NpTWhoWnVHcE5Ldm83QmFIUXEyS09rMFE2QXlSUVQ3Wk42VzRvdExYNWV1YzIyazNCelpCMGFheEpwQS1UNDE3UHRQT2hCV2ticHB2cTZSODhyVGFlSUoyS0h5c0stU2tDRmlqN2t6akNmNUp2UmQ0MkdRaXVtalhCc3JMcHl4aEFiemdob1lLaEFCbUE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirgFBVV95cUxOT0lTMzdJb2diVXhDLTBMRE9xdmVjOHJUS0NpTWhoWnVHcE5Ldm83QmFIUXEyS09rMFE2QXlSUVQ3Wk42VzRvdExYNWV1YzIyazNCelpCMGFheEpwQS1UNDE3UHRQT2hCV2ticHB2cTZSODhyVGFlSUoyS0h5c0stU2tDRmlqN2t6akNmNUp2UmQ0MkdRaXVtalhCc3JMcHl4aEFiemdob1lLaEFCbUE?oc=5\" target=\"_blank\">Biotech company Amgen set to build $600-million research center in Thousand Oaks</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Los Angeles Times</font>",
      "published": "2025-09-04T07:00:00+00:00",
      "source": "Los Angeles Times"
    },
    {
      "title": "AMGEN INVESTING MORE THAN HALF A BILLION DOLLARS IN NEW, STATE-OF-THE-ART CENTER FOR SCIENCE AND INNOVATION AT U.S. GLOBAL HEADQUARTERS - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMilwJBVV95cUxNVFhTTTRXUXRfTEdWRVJMZ0RxZkRKeU1GTmJjN0FwMWVpRG9lMmNBeWIyd2U3NXNMMGJCcmY4b0Q3REJDLXRFREpSRHdVNVN3NW5rcUEwZFp2S0c2VkREb193RGc2dTRIcU53VVdSUlVjMlY3dGZxcWFCWnR4cnZjUDU5aU5BUEZmN1g4YjZDNzNUamREam1uTGMzWGZrUU80UjJUTTMySFZXZHBmQU4xdG96NEZ1dGxLajBiZTd2d3pFM0xZejJpQ2pqbkRyZW5ud2lZMzlJSXUybjJ4ckZueFloYjNZT0pXbmZsVkljSVViX09MTWN2bjVQRHVnM19MbnNJYm5YRFVwVExlV1FEaUk5WFRsOUk?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilwJBVV95cUxNVFhTTTRXUXRfTEdWRVJMZ0RxZkRKeU1GTmJjN0FwMWVpRG9lMmNBeWIyd2U3NXNMMGJCcmY4b0Q3REJDLXRFREpSRHdVNVN3NW5rcUEwZFp2S0c2VkREb193RGc2dTRIcU53VVdSUlVjMlY3dGZxcWFCWnR4cnZjUDU5aU5BUEZmN1g4YjZDNzNUamREam1uTGMzWGZrUU80UjJUTTMySFZXZHBmQU4xdG96NEZ1dGxLajBiZTd2d3pFM0xZejJpQ2pqbkRyZW5ud2lZMzlJSXUybjJ4ckZueFloYjNZT0pXbmZsVkljSVViX09MTWN2bjVQRHVnM19MbnNJYm5YRFVwVExlV1FEaUk5WFRsOUk?oc=5\" target=\"_blank\">AMGEN INVESTING MORE THAN HALF A BILLION DOLLARS IN NEW, STATE-OF-THE-ART CENTER FOR SCIENCE AND INNOVATION AT U.S. GLOBAL HEADQUARTERS</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2025-09-02T07:00:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Amgen to build $600M R&D site, hire hundreds in California - Fierce Biotech",
      "link": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNc21wQWNyQzRTYlVhOGhCTTZSME1WbGRIQk8yOXFVTkpBYUxjRHVGRzFTN2Izc0RILTVsZV9WTncwdGNsU3dJQVRwVzAtYW1VQUFCcmc2LUZqcUNPalU1YWRjd2hrSVE5b0NQQVFwSGxZM2lsVlAzbmF6bllFQ3dLLWZiNW9fRkJYR00tYVZSUVA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikAFBVV95cUxNc21wQWNyQzRTYlVhOGhCTTZSME1WbGRIQk8yOXFVTkpBYUxjRHVGRzFTN2Izc0RILTVsZV9WTncwdGNsU3dJQVRwVzAtYW1VQUFCcmc2LUZqcUNPalU1YWRjd2hrSVE5b0NQQVFwSGxZM2lsVlAzbmF6bllFQ3dLLWZiNW9fRkJYR00tYVZSUVA?oc=5\" target=\"_blank\">Amgen to build $600M R&amp;D site, hire hundreds in California</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Biotech</font>",
      "published": "2025-09-02T07:00:00+00:00",
      "source": "Fierce Biotech"
    },
    {
      "title": "Amgen to invest $600 million in new research and development facility in California - CNBC",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPeUZXeW1BRmhhMHlWS1hTRFJCeU90NzhBdlhrMFB6QkRCcFZ5TkItczBLYi1jbFJXc1Zwa2M4eE5oZkRMV2NGNm81Z19JTzNFQmpnemZMbVBtSldIbGZhM3ptQVpJTVFEcGIwTjdnY0VRdkQtZVRzYmJBVl85dWxsdE1B0gGHAUFVX3lxTE5jZkRfXzBpOUZMOU5SaUdOQjFTX3N3X05JREVGZkNzdE1EVWwzUGE3QlQzNWd4NkV2UFJ5MlhvNW9JUTBFRl9Id1kzSWRIY0RkSnJDZUhIQmZtTzBEUzFLOGVJRGhvcWJlMTlOVGJPUDN5MktiSGlmbjJUd3BVS0pCU1A5NlZxdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxPeUZXeW1BRmhhMHlWS1hTRFJCeU90NzhBdlhrMFB6QkRCcFZ5TkItczBLYi1jbFJXc1Zwa2M4eE5oZkRMV2NGNm81Z19JTzNFQmpnemZMbVBtSldIbGZhM3ptQVpJTVFEcGIwTjdnY0VRdkQtZVRzYmJBVl85dWxsdE1B0gGHAUFVX3lxTE5jZkRfXzBpOUZMOU5SaUdOQjFTX3N3X05JREVGZkNzdE1EVWwzUGE3QlQzNWd4NkV2UFJ5MlhvNW9JUTBFRl9Id1kzSWRIY0RkSnJDZUhIQmZtTzBEUzFLOGVJRGhvcWJlMTlOVGJPUDN5MktiSGlmbjJUd3BVS0pCU1A5NlZxdw?oc=5\" target=\"_blank\">Amgen to invest $600 million in new research and development facility in California</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font>",
      "published": "2025-09-02T07:00:00+00:00",
      "source": "CNBC"
    }
  ],
  "product_launches": [
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T13:07:30+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5\" target=\"_blank\">Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-01-28T08:00:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    },
    {
      "title": "Sandoz files antitrust suit in latest bid to launch biosimilar of Amgen's Enbrel in US - FirstWord Pharma",
      "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5VckVQdjB2RUpTc0p0YU1DYnpKMGJHbUt0b3djeEI1Sk91Mm9NLWJPQmpLUEhNYUtBZ1BUa21RVlQxcEhHdXpMa3dNMUs4NTd5dDhn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5VckVQdjB2RUpTc0p0YU1DYnpKMGJHbUt0b3djeEI1Sk91Mm9NLWJPQmpLUEhNYUtBZ1BUa21RVlQxcEhHdXpMa3dNMUs4NTd5dDhn?oc=5\" target=\"_blank\">Sandoz files antitrust suit in latest bid to launch biosimilar of Amgen's Enbrel in US</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FirstWord Pharma</font>",
      "published": "2025-04-14T07:00:00+00:00",
      "source": "FirstWord Pharma"
    },
    {
      "title": "Amgen Confirms Launch Of First US Eculizumab Rival - insights.citeline.com",
      "link": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5\" target=\"_blank\">Amgen Confirms Launch Of First US Eculizumab Rival</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">insights.citeline.com</font>",
      "published": "2025-03-05T08:00:00+00:00",
      "source": "insights.citeline.com"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-09-15",
      "close": 274.3999938964844
    },
    "history": [
      {
        "date": "2025-09-05",
        "close": 283.6400146484375
      },
      {
        "date": "2025-09-08",
        "close": 280.19000244140625
      },
      {
        "date": "2025-09-09",
        "close": 279.9700012207031
      },
      {
        "date": "2025-09-10",
        "close": 278.510009765625
      },
      {
        "date": "2025-09-11",
        "close": 282.7300109863281
      },
      {
        "date": "2025-09-12",
        "close": 276.3900146484375
      },
      {
        "date": "2025-09-15",
        "close": 274.3999938964844
      }
    ],
    "name": "Amgen Inc."
  }
}